Nihonium

From WikiMD's Wellness Encyclopedia

Nihonium is a synthetic chemical element with the symbol Nh and atomic number 113. It is a highly radioactive element and is placed in the Periodic Table in the p-block, belonging to the 7th period and group 13, making it a part of the Post-transition metals. Nihonium was first synthesized in 2004 by a team of Russian and American scientists at the Joint Institute for Nuclear Research (JINR) in Dubna, Russia, and later confirmed by a team of Japanese scientists at the RIKEN institute. The name "Nihonium" originates from "Nihon," which is one of the two ways to say "Japan" in Japanese, honoring the country where it was discovered.

Properties[edit | edit source]

Nihonium is expected to be a solid under normal conditions but has not been observed in macroscopic quantities, and its properties have not been conclusively studied. Theoretical calculations suggest that Nihonium and its compounds might exhibit some metallic characteristics, similar to its lighter homologs in the group, such as Thallium. Due to its position in the periodic table, it is anticipated to have a +1 oxidation state in most of its compounds.

Synthesis and Discovery[edit | edit source]

The discovery of Nihonium was a result of collaborative efforts between scientists from different countries. The first successful synthesis was achieved by bombarding a target of Americium (Am) with ions of Calcium (Ca) in a particle accelerator. The reaction produced a single atom of Nihonium:

\[ \,^{243}_{95}Am + \,^{48}_{20}Ca \rightarrow \,^{286}_{113}Nh + 5 \,^{1}_{0}n \]

This synthesis was later confirmed by independent experiments, leading to the official recognition of the discovery by the International Union of Pure and Applied Chemistry (IUPAC) and the naming of the element in 2016.

Applications[edit | edit source]

Due to its extreme rarity and radioactivity, Nihonium has no commercial applications and is used primarily for scientific research purposes. The study of Nihonium and its properties provides valuable insights into the behavior of elements in the superheavy region of the periodic table, contributing to the understanding of the underlying principles of nuclear physics and chemistry.

Safety[edit | edit source]

Nihonium is a highly radioactive element, and its isotopes have very short half-lives, decaying into lighter elements through alpha decay. Handling of Nihonium, like other superheavy elements, requires specialized facilities and strict safety protocols to protect researchers from radiation exposure.

See Also[edit | edit source]



Stub icon

This chemical element related article is a stub. You can help WikiMD by expanding it.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD